[Maintaining independence. New protease inhibitor receives drug approval recommendation].  [electronic resource] 

 -  MMW Fortschritte der Medizin  Apr 2004 
 - 84-5 p.  digital 
<br/><br/> Publication Type: News 
<br/><br/><label>ISSN: </label>1438-3276 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carbamates<br/>Clinical Trials as Topic<br/>Drug Administration Schedule<br/>Drug Approval--legislation & jurisprudence<br/>Drug Resistance, Multiple, Viral--drug effects<br/>Drug Therapy, Combination<br/>Europe<br/>Furans<br/>HIV Infections--drug therapy<br/>HIV Protease Inhibitors--adverse effects<br/>HIV-1--drug effects<br/>Humans<br/>Organophosphates--adverse effects<br/>Sulfonamides--adverse effects<br/>Viral Load